Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice. [electronic resource]
Producer: 20181024Description: 395-401 p. digitalISSN:- 1559-0100
- Adenocarcinoma, Follicular -- drug therapy
- Adenoma, Oxyphilic -- drug therapy
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Axitinib
- Carcinoma, Papillary -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Imidazoles -- therapeutic use
- Indazoles -- therapeutic use
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Quinolines
- Sorafenib
- Survival Rate
- Thyroid Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.